TIDMGSK

RNS Number : 5383D

GlaxoSmithKline PLC

28 October 2020

   GlaxoSmithKline plc   (the ' Company ') 

Transaction notification

 
 1.    Details of PDMR/person closely associated with them 
        ('PCA') 
====  ============================================================================================ 
 a)    Name                                     Sir Jonathan Symonds 
====  ========================================  ================================================== 
 b)    Position/status                          Non-Executive Chairman 
====  ========================================  ================================================== 
 c)    Initial notification/                    Initial notification 
        amendment 
====  ========================================  ================================================== 
 2.    Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
====  ============================================================================================ 
 a)    Name                                     GlaxoSmithKline plc 
====  ========================================  ================================================== 
 b)    LEI                                      5493000HZTVUYLO1D793 
====  ========================================  ================================================== 
 3.    Details of the transaction(s): section to be repeated 
        for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transaction(s) 
        has been conducted 
====  ============================================================================================ 
 a)    Description of                           Ordinary shares of 25 pence each ('Ordinary 
        the financial                            Shares') 
        instrument                               ISIN: GB0009252882 
====  ========================================  ================================================== 
 b)    Nature of the                            Acquisition of notional Ordinary Shares 
        transaction                              under the share allocation arrangements 
                                                 for Non-Executive Directors for the period 
                                                 of service from 1 July 2020 to 30 September 
                                                 2020. 
====  ========================================  ================================================== 
 c)    Price(s) and                              Price(s)                Volume(s) 
        volume(s) 
====  ========================================   ======================  ======================= 
   GBP13.50                                                              3,240.741 
   ====================================================================  ======================= 
 
 d)    Aggregated information                   N/A (single transaction) 
==== 
  Aggregated volume 
   Price 
 =================================================================  ============================== 
 e)    Date of the transaction                  2020-10-28 
====  ========================================  ================================================== 
 f)    Place of the                             N/A 
        transaction 
====  ========================================  ================================================== 
 
 
 1.    Details of PDMR/person closely associated with them 
        ('PCA') 
====  =============================================================================================== 
 a)    Name                                     Mr Charles Bancroft 
====  ========================================  ===================================================== 
 b)    Position/status                          Independent Non-Executive Director 
====  ========================================  ===================================================== 
 c)    Initial notification/                    Initial notification 
        amendment 
====  ========================================  ===================================================== 
 2.    Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
====  =============================================================================================== 
 a)    Name                                     GlaxoSmithKline plc 
====  ========================================  ===================================================== 
 b)    LEI                                      5493000HZTVUYLO1D793 
====  ========================================  ===================================================== 
 3.    Details of the transaction(s): section to be repeated 
        for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transaction(s) 
        has been conducted 
====  =============================================================================================== 
 a)    Description of                           American Depositary Shares ('ADSs') 
        the financial                            ISIN: US37733W1053 
        instrument 
====  ========================================  ===================================================== 
 b)    Nature of the                            Acquisition of notional ADSs under the 
        transaction                              share allocation arrangements for Non-Executive 
                                                 Directors for the period of service from 
                                                 1 July 2020 to 30 September 2020. 
====  ========================================  ===================================================== 
 c)    Price(s) and                              Price(s)                 Volume(s) 
        volume(s) 
====  ========================================   =======================  ========================= 
                                                 $35.29                   866.616 
                                                 =======================  ========================= 
 
 d)    Aggregated information                   N/A (single transaction) 
==== 
  Aggregated volume 
   Price 
 =========================================  ========================================================= 
 e)    Date of the transaction                  2020-10-28 
====  ========================================  ===================================================== 
 f)    Place of the                             N/A 
        transaction 
====  ========================================  ===================================================== 
 
 
 1.    Details of PDMR/person closely associated with them 
        ('PCA') 
====  ============================================================================================ 
 a)    Name                                     Mr Vindi Banga 
====  ========================================  ================================================== 
 b)    Position/status                          Senior Independent Non-Executive Director 
====  ========================================  ================================================== 
 c)    Initial notification/                    Initial notification 
        amendment 
====  ========================================  ================================================== 
 2.    Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
====  ============================================================================================ 
 a)    Name                                     GlaxoSmithKline plc 
====  ========================================  ================================================== 
 b)    LEI                                      5493000HZTVUYLO1D793 
====  ========================================  ================================================== 
 3.    Details of the transaction(s): section to be repeated 
        for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transaction(s) 
        has been conducted 
====  ============================================================================================ 
 a)    Description of                           Ordinary shares of 25 pence each ('Ordinary 
        the financial                            Shares') 
        instrument                               ISIN: GB0009252882 
====  ========================================  ================================================== 
 b)    Nature of the                            Acquisition of notional Ordinary Shares 
        transaction                              under the share allocation arrangements 
                                                 for Non-Executive Directors for the period 
                                                 of service from 1 July 2020 to 30 September 
                                                 2020. 
====  ========================================  ================================================== 
 c)    Price(s) and                              Price(s)                Volume(s) 
        volume(s) 
====  ========================================   ======================  ======================= 
   GBP13.50                                                              671.296 
   ====================================================================  ======================= 
 
 d)    Aggregated information                   N/A (single transaction) 
==== 
  Aggregated volume 
   Price 
 =================================================================  ============================== 
 e)    Date of the transaction                  2020-10-28 
====  ========================================  ================================================== 
 f)    Place of the                             N/A 
        transaction 
====  ========================================  ================================================== 
 
 
 1.    Details of PDMR/person closely associated with them 
        ('PCA') 
====  ============================================================================================ 
 a)    Name                                     Dr Vivienne Cox 
====  ========================================  ================================================== 
 b)    Position/status                          Independent Non-Executive Director 
====  ========================================  ================================================== 
 c)    Initial notification/                    Initial notification 
        amendment 
====  ========================================  ================================================== 
 2.    Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
====  ============================================================================================ 
 a)    Name                                     GlaxoSmithKline plc 
====  ========================================  ================================================== 
 b)    LEI                                      5493000HZTVUYLO1D793 
====  ========================================  ================================================== 
 3.    Details of the transaction(s): section to be repeated 
        for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transaction(s) 
        has been conducted 
====  ============================================================================================ 
 a)    Description of                           Ordinary shares of 25 pence each ('Ordinary 
        the financial                            Shares') 
        instrument                               ISIN: GB0009252882 
====  ========================================  ================================================== 
 b)    Nature of the                            Acquisition of notional Ordinary Shares 
        transaction                              under the share allocation arrangements 
                                                 for Non-Executive Directors for the period 
                                                 of service from 1 July 2020 to 30 September 
                                                 2020. 
====  ========================================  ================================================== 
 c)    Price(s) and                              Price(s)                Volume(s) 
        volume(s) 
====  ========================================   ======================  ======================= 
   GBP13.50                                                              625.000 
   ====================================================================  ======================= 
 
 d)    Aggregated information                   N/A (single transaction) 
==== 
  Aggregated volume 
   Price 
 =================================================================  ============================== 
 e)    Date of the transaction                  2020-10-28 
====  ========================================  ================================================== 
 f)    Place of the                             N/A 
        transaction 
====  ========================================  ================================================== 
 
 
 1.    Details of PDMR/person closely associated with them 
        ('PCA') 
====  =============================================================================================== 
 a)    Name                                     Ms Lynn Elsenhans 
====  ========================================  ===================================================== 
 b)    Position/status                          Independent Non-Executive Director 
====  ========================================  ===================================================== 
 c)    Initial notification/                    Initial notification 
        amendment 
====  ========================================  ===================================================== 
 2.    Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
====  =============================================================================================== 
 a)    Name                                     GlaxoSmithKline plc 
====  ========================================  ===================================================== 
 b)    LEI                                      5493000HZTVUYLO1D793 
====  ========================================  ===================================================== 
 3.    Details of the transaction(s): section to be repeated 
        for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transaction(s) 
        has been conducted 
====  =============================================================================================== 
 a)    Description of                           American Depositary Shares ('ADSs') 
        the financial                            ISIN: US37733W1053 
        instrument 
====  ========================================  ===================================================== 
 b)    Nature of the                            Acquisition of notional ADSs under the 
        transaction                              share allocation arrangements for Non-Executive 
                                                 Directors for the period of service from 
                                                 1 July 2020 to 30 September 2020. 
====  ========================================  ===================================================== 
 c)    Price(s) and                              Price(s)                 Volume(s) 
        volume(s) 
====  ========================================   =======================  ========================= 
                                                 $35.29                   615.753 
                                                 =======================  ========================= 
 
 d)    Aggregated information                   N/A (single transaction) 
==== 
  Aggregated volume 
   Price 
 =========================================  ========================================================= 
 e)    Date of the transaction                  2020-10-28 
====  ========================================  ===================================================== 
 f)    Place of the                             N/A 
        transaction 
====  ========================================  ===================================================== 
 
 
 1.    Details of PDMR/person closely associated with them 
        ('PCA') 
====  =============================================================================================== 
 a)    Name                                     Dr Laurie Glimcher 
====  ========================================  ===================================================== 
 b)    Position/status                          Independent Non-Executive Director 
====  ========================================  ===================================================== 
 c)    Initial notification/                    Initial notification 
        amendment 
====  ========================================  ===================================================== 
 2.    Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
====  =============================================================================================== 
 a)    Name                                     GlaxoSmithKline plc 
====  ========================================  ===================================================== 
 b)    LEI                                      5493000HZTVUYLO1D793 
====  ========================================  ===================================================== 
 3.    Details of the transaction(s): section to be repeated 
        for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transaction(s) 
        has been conducted 
====  =============================================================================================== 
 a)    Description of                           American Depositary Shares ('ADSs') 
        the financial                            ISIN: US37733W1053 
        instrument 
====  ========================================  ===================================================== 
 b)    Nature of the                            Acquisition of notional ADSs under the 
        transaction                              share allocation arrangements for Non-Executive 
                                                 Directors for the period of service from 
                                                 1 July 2020 to 30 September 2020. 
====  ========================================  ===================================================== 
 c)    Price(s) and                              Price(s)                 Volume(s) 
        volume(s) 
====  ========================================   =======================  ========================= 
                                                 $35.29                   1,140.284 
                                                 =======================  ========================= 
 
 d)    Aggregated information                   N/A (single transaction) 
==== 
  Aggregated volume 
   Price 
 =========================================  ========================================================= 
 e)    Date of the transaction                  2020-10-28 
====  ========================================  ===================================================== 
 f)    Place of the                             N/A 
        transaction 
====  ========================================  ===================================================== 
 
 
 1.    Details of PDMR/person closely associated with them 
        ('PCA') 
====  =============================================================================================== 
 a)    Name                                     Dr Jesse Goodman 
====  ========================================  ===================================================== 
 b)    Position/status                          Independent Non-Executive Director 
====  ========================================  ===================================================== 
 c)    Initial notification/                    Initial notification 
        amendment 
====  ========================================  ===================================================== 
 2.    Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
====  =============================================================================================== 
 a)    Name                                     GlaxoSmithKline plc 
====  ========================================  ===================================================== 
 b)    LEI                                      5493000HZTVUYLO1D793 
====  ========================================  ===================================================== 
 3.    Details of the transaction(s): section to be repeated 
        for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transaction(s) 
        has been conducted 
====  =============================================================================================== 
 a)    Description of                           American Depositary Shares ('ADSs') 
        the financial                            ISIN: US37733W1053 
        instrument 
====  ========================================  ===================================================== 
 b)    Nature of the                            Acquisition of notional ADSs under the 
        transaction                              share allocation arrangements for Non-Executive 
                                                 Directors for the period of service from 
                                                 1 July 2020 to 30 September 2020. 
====  ========================================  ===================================================== 
 c)    Price(s) and                              Price(s)                 Volume(s) 
        volume(s) 
====  ========================================   =======================  ========================= 
                                                 $35.29                   376.294 
                                                 =======================  ========================= 
 
 d)    Aggregated information                   N/A (single transaction) 
==== 
  Aggregated volume 
   Price 
 =========================================  ========================================================= 
 e)    Date of the transaction                  2020-10-28 
====  ========================================  ===================================================== 
 f)    Place of the                             N/A 
        transaction 
====  ========================================  ===================================================== 
 
 
 1.    Details of PDMR/person closely associated with them 
        ('PCA') 
====  =============================================================================================== 
 a)    Name                                     Ms Judy Lewent 
====  ========================================  ===================================================== 
 b)    Position/status                          Independent Non-Executive Director 
====  ========================================  ===================================================== 
 c)    Initial notification/                    Initial notification 
        amendment 
====  ========================================  ===================================================== 
 2.    Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
====  =============================================================================================== 
 a)    Name                                     GlaxoSmithKline plc 
====  ========================================  ===================================================== 
 b)    LEI                                      5493000HZTVUYLO1D793 
====  ========================================  ===================================================== 
 3.    Details of the transaction(s): section to be repeated 
        for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transaction(s) 
        has been conducted 
====  =============================================================================================== 
 a)    Description of                           American Depositary Shares ('ADSs') 
        the financial                            ISIN: US37733W1053 
        instrument 
====  ========================================  ===================================================== 
 b)    Nature of the                            Acquisition of notional ADSs under the 
        transaction                              share allocation arrangements for Non-Executive 
                                                 Directors for the period of service from 
                                                 1 July 2020 to 30 September 2020. 
====  ========================================  ===================================================== 
 c)    Price(s) and                              Price(s)                 Volume(s) 
        volume(s) 
====  ========================================   =======================  ========================= 
                                                 $35.29                   399.099 
                                                 =======================  ========================= 
 
 d)    Aggregated information                   N/A (single transaction) 
==== 
  Aggregated volume 
   Price 
 =========================================  ========================================================= 
 e)    Date of the transaction                  2020-10-28 
====  ========================================  ===================================================== 
 f)    Place of the                             N/A 
        transaction 
====  ========================================  ===================================================== 
 
 
 1.    Details of PDMR/person closely associated with them 
        ('PCA') 
====  ============================================================================================ 
 a)    Name                                     Mr Urs Rohner 
====  ========================================  ================================================== 
 b)    Position/status                          Independent Non-Executive Director 
====  ========================================  ================================================== 
 c)    Initial notification/                    Initial notification 
        amendment 
====  ========================================  ================================================== 
 2.    Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
====  ============================================================================================ 
 a)    Name                                     GlaxoSmithKline plc 
====  ========================================  ================================================== 
 b)    LEI                                      5493000HZTVUYLO1D793 
====  ========================================  ================================================== 
 3.    Details of the transaction(s): section to be repeated 
        for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transaction(s) 
        has been conducted 
====  ============================================================================================ 
 a)    Description of                           Ordinary shares of 25 pence each ('Ordinary 
        the financial                            Shares') 
        instrument                               ISIN: GB0009252882 
====  ========================================  ================================================== 
 b)    Nature of the                            Acquisition of notional Ordinary Shares 
        transaction                              under the share allocation arrangements 
                                                 for Non-Executive Directors for the period 
                                                 of service from 1 July 2020 to 30 September 
                                                 2020. 
====  ========================================  ================================================== 
 c)    Price(s) and                              Price(s)                Volume(s) 
        volume(s) 
====  ========================================   ======================  ======================= 
   GBP13.50                                                              625.000 
   ====================================================================  ======================= 
 
 d)    Aggregated information                   N/A (single transaction) 
==== 
  Aggregated volume 
   Price 
 =================================================================  ============================== 
 e)    Date of the transaction                  2020-10-28 
====  ========================================  ================================================== 
 f)    Place of the                             N/A 
        transaction 
====  ========================================  ================================================== 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHDVLFLBBLZFBE

(END) Dow Jones Newswires

October 28, 2020 13:46 ET (17:46 GMT)

Grafico Azioni Glaxosmithkline (LSE:GSK)
Storico
Da Ott 2020 a Nov 2020 Clicca qui per i Grafici di Glaxosmithkline
Grafico Azioni Glaxosmithkline (LSE:GSK)
Storico
Da Nov 2019 a Nov 2020 Clicca qui per i Grafici di Glaxosmithkline